Literature DB >> 9452825

Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study.

I Akiguchi1, H Tomimoto, T Suenaga, H Wakita, H Budka.   

Abstract

Binswanger's disease is pathologically characterized by a combination of diffuse cerebrovascular white matter lesions and lacunar infarcts in the basal ganglia and white matter. Although a blood-brain barrier (BBB) dysfunction has been implicated in the pathogenesis of these white matter (WM) lesions, few authors have addressed this problem. In the present study, we describe BBB dysfunction and its regional differences in the brains of Binswanger's disease patients. Twelve brains from Binswanger's disease patients (group III) were examined and compared with those from five patients with non-neurological disease (group I) and five cortical infarct patients without significant WM lesions (group II). Immunohistochemistry was performed for glial fibrillary acidic protein and vimentin as astroglial cell markers, and for immunoglobulins, complements and fibrinogen as extravasated serum protein markers. The grading scores for IgG extravasation were significantly higher in group III as compared to group I, in both the periventricular WM and the subcortical WM (P < 0.01). In group III, the scores in the periventricular WM and subcortical WM were significantly higher than in the subcortical U fibers and cerebral cortex (P < 0.01 for the periventricular WM; P < 0.001 for the subcortical WM), respectively. Clasmatodendritic astroglia, which had swollen cell bodies and large cytoplasmic vacuoles with disintegrated processes, incorporated the serum components IgG, IgM, C3d, Clq and fibrinogen, both in the periventricular WM and subcortical WM in 5 out of 12 (42%) Binswanger's disease brains. These results indicate that WM lesions in Binswanger's disease are accompanied by BBB dysfunction, although it remains uncertain whether BBB dysfunction is secondary to either chronic cerebral ischemia or arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452825     DOI: 10.1007/s004010050768

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

Review 1.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 2.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

3.  The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Yoshitomo Shirakashi; Emi Kotani; Masahiro Yoshimura; Shigehiro Morikawa; Toshiro Inubushi; Ichiro Akiguchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

4.  Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Authors:  Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

Review 5.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

6.  In vivo vascular hallmarks of diffuse leukoaraiosis.

Authors:  Jinsoo Uh; Uma Yezhuvath; Yamei Cheng; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

7.  Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.

Authors:  Eduardo Candelario-Jalil; Jeffrey Thompson; Saeid Taheri; Mark Grossetete; John C Adair; Elaine Edmonds; Jillian Prestopnik; John Wills; Gary A Rosenberg
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

Review 8.  Emerging insights from the genetics of cerebral small-vessel disease.

Authors:  Loes C A Rutten-Jacobs; Natalia S Rost
Journal:  Ann N Y Acad Sci       Date:  2019-01-08       Impact factor: 5.691

9.  Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage.

Authors:  Min Lou; Adel Al-Hazzani; Richard P Goddeau; Vera Novak; Magdy Selim
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

10.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study.

Authors:  Myriam Fornage; Y Aron Chiang; Ellen S O'Meara; Bruce M Psaty; Alexander P Reiner; David S Siscovick; Russell P Tracy; W T Longstreth
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.